中文

赛升药业 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-29
ItemAmountY/Y
Revenue¥0.09B-2.3%
Gross profit¥0.06B
Operating income¥0.00B
Net income¥0.00B-90.2%
Gross margin68.1%Net margin 4.2%
Revenue Q/Q-5.9%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.03B31.9%
R&D¥0.01B9.2%
SG&A¥0.04B48.0%
Tax & other¥-0.00B-0.1%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

东杰智能蓝晓科技恒锋工具光智科技华自科技通合科技华图山鼎润欣科技盛天网络中科创达富祥股份高澜股份

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies